Search Results - "Madura, Florian"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Structural basis for ineffective T‐cell responses to MHC anchor residue‐improved “heteroclitic” peptides by Madura, Florian, Rizkallah, Pierre J., Holland, Christopher J., Fuller, Anna, Bulek, Anna, Godkin, Andrew J., Schauenburg, Andrea J., Cole, David K., Sewell, Andrew K.

    Published in European journal of immunology (01-02-2015)
    “…MHC anchor residue‐modified “heteroclitic” peptides have been used in many cancer vaccine trials and often induce greater immune responses than the wild‐type…”
    Get full text
    Journal Article
  6. 6
  7. 7

    T-cell Receptor Specificity Maintained by Altered Thermodynamics by Madura, Florian, Rizkallah, Pierre J., Miles, Kim M., Holland, Christopher J., Bulek, Anna M., Fuller, Anna, Schauenburg, Andrea J.A., Miles, John J., Liddy, Nathaniel, Sami, Malkit, Li, Yi, Hossain, Moushumi, Baker, Brian M., Jakobsen, Bent K., Sewell, Andrew K., Cole, David K.

    Published in The Journal of biological chemistry (28-06-2013)
    “…The T-cell receptor (TCR) recognizes peptides bound to major histocompatibility molecules (MHC) and allows T-cells to interrogate the cellular proteome for…”
    Get full text
    Journal Article
  8. 8

    Enhanced Detection of Antigen-Specific CD4+ T Cells Using Altered Peptide Flanking Residue Peptide-MHC Class II Multimers by Holland, Christopher J, Dolton, Garry, Scurr, Martin, Ladell, Kristin, Schauenburg, Andrea J, Miners, Kelly, Madura, Florian, Sewell, Andrew K, Price, David A, Cole, David K, Godkin, Andrew J

    Published in The Journal of immunology (1950) (15-12-2015)
    “…Fluorochrome-conjugated peptide-MHC (pMHC) class I multimers are staple components of the immunologist's toolbox, enabling reliable quantification and analysis…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Real time detection of peptide–MHC dissociation reveals that improvement of primary MHC-binding residues can have a minimal, or no, effect on stability by Miles, Kim M., Miles, John J., Madura, Florian, Sewell, Andrew K., Cole, David K.

    Published in Molecular immunology (01-01-2011)
    “…The majority of known major histocompatibility complex class I (MHCI)-associated tumor-derived peptide antigens do not contain an optimal motif for MHCI…”
    Get full text
    Journal Article
  11. 11

    TCR/pMHC Optimized Protein crystallization Screen by Bulek, Anna M., Madura, Florian, Fuller, Anna, Holland, Christopher J., Schauenburg, Andrea J.A., Sewell, Andrew K., Rizkallah, Pierre J., Cole, David K.

    Published in Journal of immunological methods (31-08-2012)
    “…The interaction between the clonotypic αβ T cell receptor (TCR), expressed on the T cell surface, and peptide-major histocompatibility complex (pMHC)…”
    Get full text
    Journal Article
  12. 12

    Minimal conformational plasticity enables TCR cross-reactivity to different MHC class II heterodimers by Holland, Christopher J., Rizkallah, Pierre J., Vollers, Sabrina, Calvo-Calle, J. Mauricio, Madura, Florian, Fuller, Anna, Sewell, Andrew K., Stern, Lawrence J., Godkin, Andrew, Cole, David K.

    Published in Scientific reports (04-09-2012)
    “…Successful immunity requires that a limited pool of αβ T-cell receptors (TCRs) provide cover for a vast number of potential foreign peptide antigens presented…”
    Get full text
    Journal Article
  13. 13

    Structural and biophysical insights from targeting melanoma using genetically modified t-cell receptors by Madura, Florian

    Published 01-01-2013
    “…CD8+ T-cells recognise pathogens and cancer through a specific interaction between the T-cell receptor (TCR) and a 8-14 amino-acid residue peptide presented by…”
    Get full text
    Dissertation
  14. 14
  15. 15
  16. 16
  17. 17